Newsfeeds Archive - Page 2 of 8

1 minute read

Watching ACADIA Pharmaceuticals; Traders Circulate “ACADIA Pharmaceuticals Wins Summary Judgement In A Patent Suit Regarding Its Drug Nuplazid, Which Is Used To Treat Parkinson’s Disease, Against Generic Maker MSN Laboratories”; Shares Now Up 27%

By Benzinga Newsdesk

December 13, 11:25 AM

Acadia Pharmaceuticals stock surges 32% after win in patent suit over Nuplazid | Seeking Alpha

ACAD

2 minute read

Analyst Ratings

Analyst Ratings for ACADIA Pharmaceuticals

By Benzinga Insights

December 12, 9:00 AM

Analysts have provided the following ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD) within the last quarter: Bullish Somewhat Bullish Indifferent…

ACAD

2 minute read

Analyst Ratings

What 7 Analyst Ratings Have To Say About ACADIA Pharmaceuticals

By Benzinga Insights

November 6, 10:00 AM

Over the past 3 months, 7 analysts have published their opinion on ACADIA Pharmaceuticals (NASDAQ:ACAD) stock. These analysts…

ACAD

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

November 2, 1:35 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

ABT

29 minute read

Earnings

Earnings Scheduled For November 2, 2023

By Benzinga Insights

November 2, 4:56 AM

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.

AAPL

20 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 17, 2023

By Benzinga Insights

October 17, 11:00 AM

Upgrades According to Wolfe Research, the prior rating for TC Energy Corp (NYSE:TRP) was changed from Underperform to…

ACA

1 minute read

Analyst Ratings

Analyst Ratings for ACADIA Pharmaceuticals

By Benzinga Insights

October 10, 11:00 AM

Analysts have provided the following ratings for ACADIA Pharmaceuticals (NASDAQ:ACAD) within the last quarter: Bullish Somewhat Bullish Indifferent…

ACAD

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 10, 2023

By Benzinga Insights

October 10, 11:00 AM

Upgrades According to RBC Capital, the prior rating for Montrose Environmental Group Inc (NYSE:MEG) was changed from Sector…

AAP

2 minute read

Electronic Arts To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Tuesday

By Lisa Levin

October 10, 8:23 AM

JP Morgan increased ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) price target from $29 to $32. JP Morgan analyst Tessa Romero upgraded the stock from Neutral to Overweight. ACADIA Pharmaceuticals shares rose 0.3% to close at $21.74 on Monday.

ACAD